Warning: This security is no longer trading.
Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd and will now trade under the SELLAS Life Sciences Group brand with symbol SLS
Galena Biopharma, Inc. (GALE): Price and Financial Metrics
GALE Price/Volume Stats
| Current price | $0.26 | 52-week high | $2.41 |
| Prev. close | $0.28 | 52-week low | $0.26 |
| Day low | $0.26 | Volume | 20,353,201 |
| Day high | $0.40 | Avg. volume | 1,133,821 |
| 50-day MA | $0.30 | Dividend yield | N/A |
| 200-day MA | $0.46 | Market Cap | 11.88M |
GALE Stock Price Chart Interactive Chart >
Galena Biopharma, Inc. (GALE) Company Bio
Galena Biopharma, Inc. focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. The company was founded in 2003 and is based in Portland, Oregon.
GALE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...